Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

SVB Leerink Maintains Outperform on Pharvaris, Lowers Price Target to $18

SVB Leerink analyst Joseph Schwartz maintains Pharvaris (NASDAQ:PHVS) with a Outperform and lowers the price target from $20 to $18.
byBenzinga Newsdesk
February 3, 2023
1 minute read
Total
0
Shares
0
0
0
0
0
0

SVB Leerink analyst Joseph Schwartz maintains Pharvaris (NASDAQ:PHVS) with a Outperform and lowers the price target from $20 to $18.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts